Rating History for Ligand Pharma (LGND) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/14/2026 | David Risinger | New Coverage | Outperform (N/A) |
330.00 (N/A) |
288.82 (284.27) |
-1.58% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/14/2026 | David Risinger | New Coverage | Outperform (N/A) |
330.00 (N/A) |
288.82 (284.27) |
-1.58% | Details |